Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments?
Saved in:
| Title: | Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - part II: how can key events of relevant adverse outcome pathways be addressed in toxicological assessments? |
|---|---|
| Authors: | Marty S; The Dow Chemical Company, Midland, MI, USA., Beekhuijzen M; Charles River Laboratories, Den Bosch, The Netherlands., Charlton A; Syngenta, Jealott's Hill, Bracknell, United Kingdom., Hallmark N; Bayer AG, Monheim, Germany., Hannas BR; Corteva Agriscience, Newark, DE, USA., Jacobi S; Albemarle, Louvain-la-Neuve, Belgium., Melching-Kollmuss S; BASF SE, Ludwigshafen, Germany., Sauer UG; Scientific Consultancy - Animal Welfare, Neubiberg, Germany., Sheets LP; Bayer Crop Science, Chesterfield, MO, USA., Strauss V; BASF SE, Ludwigshafen, Germany., Urbisch D; BASF SE, Ludwigshafen, Germany., Botham PA; Syngenta, Jealott's Hill, Bracknell, United Kingdom., van Ravenzwaay B; BASF SE, Ludwigshafen, Germany. |
| Source: | Critical reviews in toxicology [Crit Rev Toxicol] 2021 Apr; Vol. 51 (4), pp. 328-358. Date of Electronic Publication: 2021 Jun 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1547-6898 (Electronic) Linking ISSN: 10408444 NLM ISO Abbreviation: Crit Rev Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
